Comparative Pharmacology
Head-to-head clinical analysis: AK FLUOR 10 versus CYSVIEW KIT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AK FLUOR 10 versus CYSVIEW KIT.
AK-FLUOR 10% vs CYSVIEW KIT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Fluorescein sodium is a diagnostic dye that absorbs light in the blue spectrum (465-490 nm) and emits green-yellow fluorescence (520-530 nm). It is used to visualize blood flow, detect corneal abrasions, and assess vascular integrity by highlighting areas of leakage or damage.
Cholic acid is a primary bile acid that acts as a choleretic and bile acid replacement therapy. It competitively inhibits hepatic bile acid synthesis via negative feedback on cholesterol 7α-hydroxylase (CYP7A1), reducing the production of toxic bile acid intermediates in patients with inborn errors of bile acid synthesis.
Intravenous injection: 5-10 mL (500-1000 mg fluorescein sodium) given rapidly over 4-5 seconds.
Intravenous: 5 mg/kg as a single dose administered over 30 minutes.
None Documented
None Documented
Terminal elimination half-life is approximately 1-2 minutes in patients with normal renal function. This short half-life reflects rapid redistribution and renal clearance.
Terminal elimination half-life: 1.9-2.5 hours (mean 2.1 h) in normal renal function; prolonged in renal impairment (up to 20 h in ESRD).
Primarily renal (unchanged). Approximately 80-90% of an administered dose is excreted unchanged in urine within 24 hours. Biliary/fecal excretion is minimal (<5%).
Renal: 90% unchanged via glomerular filtration; biliary/fecal: <5%
Category C
Category C
Diagnostic Dye
Diagnostic Dye